| Download as PDF | |
Dr. Reddy'sHyderabad, India
Report FactsCompany name: Dr. Reddy’s LaboratoriesFiscal year end: March 31 Report title: 25 years of innovation and affordability Chairman: Dr. K. Anji Reddy Vice Chairman and CEO: G V Prasad Number of books: One Report length: 200 pages Auditors: B S R & Co. Production and design: N/A E-mail: kedaru@drreddys.com |
Report rating (Rating scale below)(3.5/5)
Profile-Products(Excerpts, as from the report)Twenty-five years since our inception, we at Dr. Reddy’s Laboratories continue our efforts to provide affordable and innovative medicines to patients across the world, either directly... or indirectly... Our strategy is to leverage research and development... to be a leading global pharmaceutical company.(Italics are own company’s words excerpted from the annual report) Key FiguresTotal revenues: RS 69,441 millionOperating income: RS (2,834 million) Net income: RS (5,168 million) Earnings per share: RS (30.69) Dividend per share: RS 6.25 Gross margin: 53% Current ratio: 1.5 Debt to equity: 0.5 (Source: 2009 figures and ratios as shown in the report) Some Competitors
|
Triple A> Company’s DNA charts the course (literally too, as shown on the selected page hereafter). The symbol is effectively used as a visual thread for the anniversary celebration.> An illustrated timeline helps get milestones, key market achievements and other salient facts. This puts last year’s decreasing figures (at least at some levels) in broader and longer strategic perspective. |
|
Double A> Overall readability and layout ahead of a large majority of Indian annuals, with special mentions for the well-made tables of contents, modern typography, the clearness of tables.> Share information, dividend history, distribution of shareholdings, and a recap of Shareholder Queries and Requests. > Relatively well-structured and well-supported MD&A. > Five Years at a Glance and the following five-year Ratio Analysis are well structured and include classic plus less often encountered indicators, such as Fixed Assets Turnover, Working Capital Turnover, Inventory Turnover, Current Ratio... |
|
Simple A> Chairman’s message puts the strategy and operations in a medium-term perspective but is far from sufficiently developed as regards last year underperformance.> Good level of disclosure and transparency on governance and leadership. |
|
B sides> 200 pages: not the lightest volume. And it takes some time to get some key information, such as a real profile or business description, major ratios, etc.> Financial highlights should have been more explicit, especially about last year poor result performance. > Risk analysis not up to general and industry requirements. |
|
|
How does the company report in key areas? What are the main report pluses and minuses?
The Report Scan gives an overview of strengths and weaknesses, and scores each item.
|
|
Selected Page(p 5 of Dr. Reddy’s Laboratories Annual Report 2009)
|
|
Reportwatch
"In many organizations, the riskJulian Birkinshaw and Huw Jenkins, <br /><em>professors at the London Business School</em>
manager is too far removed from
action to feel genuine responsibility"
REPORT OF THE MONTH
REPORT OF THE MONTH
TD Bank Financial (March 2010)
BEST ANNUAL REPORTS
Annual Report on Annual Reports 2010
How will companies report the year?
How is your report doing?
How does your annual report (printed or online) score? In total and on all evaluation criteria used for the Annual Report on Annual Reports? Order a REPORT SCAN. An edited output of desk research done by e.com report analysts, it provides your company (or advisers) with the complete score breakdown for 50 report items plus a summary of pluses and minuses for each of them.
For more information, go to www.reportwatch.net/e-com/making-reports-pay-off/
E-mail your order to: e.com@reportwatch.net
A report on capitalism
The seven deadly sins of capitalism,
by e.com founder Mike Guillaume
These are extraordinary times. Undoubtedly, the latest crisis, which is far from behind us, has knocked the system off its pedestal.
More on http://www.mikeconomics.net
